Cite
HARVARD Citation
Kumar, R. et al. (2018). The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective. International journal of cardiology. pp. 183-187. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kumar, R. et al. (2018). The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective. International journal of cardiology. pp. 183-187. [Online].